DAVID MAHONEY - 16 May 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Director
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for David L Mahoney.
Issuer symbol
CORT
Transactions as of
16 May 2025
Transactions value $
-$2,030,461
Form type
4
Filing time
20 May 2025, 19:13:03 UTC
Previous filing
21 May 2024
Next filing
12 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MAHONEY DAVID L Director C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY /s/ Joseph Douglas Lyon, as attorney-in-fact for David L Mahoney. 20 May 2025 0001224091

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $197K +30K $6.55 30K 16 May 2025 Direct
transaction CORT Common Stock Tax liability -$197K -2.65K -8.83% $74.21 27.4K 16 May 2025 Direct F1
transaction CORT Common Stock Sale -$1.77M -23.8K -87.12% $74.17 3.52K 16 May 2025 Direct F2
transaction CORT Common Stock Sale -$263K -3.52K -100% $74.65 0 16 May 2025 Direct F3
holding CORT Common Stock 1.21M 16 May 2025 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust
holding CORT Common Stock 46.1K 16 May 2025 The Black Dog Private Foundation

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -30K -100% $0.00 0 16 May 2025 Common Stock 30K $6.55 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price liability arising from a net (cashless) exercise of stock options that occurred on May 16, 2025. The options subject to the net exercise were to expire on June 18, 2025.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.54 to $74.525 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
F3 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $74.54 to $74.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
F4 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.